Paradigm Capital Management (Nevada)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-480
Closed -$374K 62
2025
Q2
$374K Hold
480
0.37% 46
2025
Q1
$396K Hold
480
0.4% 42
2024
Q4
$371K Hold
480
0.35% 49
2024
Q3
$425K Buy
+480
New +$432K 0.41% 45

Other funds holding LLY

Paradigm Capital Management (Nevada)'s LLY Position: Q3 2025 in Review

Paradigm Capital Management (Nevada) sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 480 shares — an estimated $374K sold.

Paradigm Capital Management (Nevada) first reported a position in LLY in Q3 2024 and held it in 4 quarters. The position peaked at $425K in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Paradigm Capital Management (Nevada) reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Paradigm Capital Management (Nevada) sold 480 Eli Lilly shares in Q3 2025, an estimated $374K.
  • Paradigm Capital Management (Nevada) first reported a position in Eli Lilly in Q3 2024 and held it in 4 quarters.
  • Paradigm Capital Management (Nevada)'s Eli Lilly position peaked at $425K in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Paradigm Capital Management (Nevada)'s 13F filing for Q3 2025, filed 6 Nov 2025.